Cruz C, Juárez-Nicolás F, Tapia E, Correa-Rotter R, Pedraza-Chaverrí J
Departamentos de Nefrología y Metabolismo Mineral, Instituto Nacional de la Nutrición Salvador Zubirán, México DF México.
Nephron. 1994;68(4):489-96. doi: 10.1159/000188312.
The human nephrotic syndrome is accompanied by important alterations of the coagulation system related proteins. The purpose of the present study was to examine the activity of coagulation- and fibrinolysis-related proteins in plasma and urine of control and puromycin aminonucleoside injected rats on days 2 (prenephrotic stage) and 10 (nephrotic stage). We measured the prothrombin time (PT), the activated partial thromboplastin time (aPTT), and the activities of (1) the coagulation factors (CFs) I, II, V, and VII-XII; (2) the inhibitor of coagulation antithrombin III (ATIII), and (3) the component of the fibrinolytic system alpha 2-antiplasmin (alpha 2-APL). PT and aPTT and the activities of CF, ATIII, and alpha 2-APL were not measurable in the urine of control and puromycin amino-nucleoside injected rats on day 2. On this same day, plasma ATIII and CF VIII decreased. On day 10 (1) PT and aPTT decreased in plasma and were not measurable in urine; (2), plasma CFs I, II, V, VII, VIII, X, and XI increased; (3), plasma ATIII decreased; (4), plasma CFs IX and XII and alpha 2-APL did not change, and (5) ATIII and CFs II, VII, VIII, IX, X, XI, and XII, but not CFs I and V and alpha 2-APL, appeared in urine on day 10. ATIII deficiency was secondary probably to the urinary losses; however, the plasma activity of CFs II, VII, VIII, X, and XI increased and that of CFs IX and XII remained unchanged in spite of their urinary losses which suggests that other mechanisms such as deranged catabolism and altered hepatic synthesis may be involved.(ABSTRACT TRUNCATED AT 250 WORDS)
人类肾病综合征伴有凝血系统相关蛋白的重要改变。本研究的目的是检测对照大鼠和注射嘌呤霉素氨基核苷的大鼠在第2天(肾病前期)和第10天(肾病期)血浆和尿液中凝血和纤溶相关蛋白的活性。我们测定了凝血酶原时间(PT)、活化部分凝血活酶时间(aPTT)以及(1)凝血因子(CFs)I、II、V和VII - XII的活性;(2)凝血抑制剂抗凝血酶III(ATIII)的活性;(3)纤溶系统成分α2 - 抗纤溶酶(α2 - APL)的活性。在第2天,对照大鼠和注射嘌呤霉素氨基核苷的大鼠尿液中PT、aPTT以及CF、ATIII和α2 - APL的活性均无法检测到。在同一天,血浆ATIII和CF VIII降低。在第10天,(1)血浆中PT和aPTT降低,尿液中无法检测到;(2)血浆CFs I、II、V、VII、VIII、X和XI升高;(3)血浆ATIII降低;(4)血浆CFs IX和XII以及α2 - APL未改变;(5)第10天尿液中出现ATIII和CFs II、VII、VIII、IX、X、XI和XII,但CFs I和V以及α2 - APL未出现。ATIII缺乏可能继发于尿液丢失;然而,尽管CFs II、VII、VIII、X和XI有尿液丢失,但其血浆活性升高,而CFs IX和XII的血浆活性保持不变,这表明可能涉及其他机制,如分解代谢紊乱和肝脏合成改变。(摘要截选至250字)